Reneo Pharmaceuticals Inc - Class A. Every tracked FinTwit mention of $OKUR, newest first. 5 mentions since the first on Mar 20, 2026. See the price chart.
Jacob Plieth — And, just like that, $OKUR discontinues OKI-219! What I wrote in Jan: https://t.co/pcH79ObNxv↗
Mar 20
Jacob Plieth — Interesting Qs raised by Evercore's Jon Miller: $NVS will have looked at all PI3Kα players, so why did it pick Synnovation? Was it preference for pan-mut vs $OKUR mut-specific? Saf…↗
Mar 20
Jacob Plieth — $NVS follows $LLY into mutation-selective PI3Kα inhibition. What does this mean for $RLAY $OKUR & $COGT? Via @ApexOnco -> https://t.co/WAzlp5zE7a↗
Mar 20
Jacob Plieth — $NVS paying $2bn for Synnovation's SNV4818, after $LLY paid $1.5bn for Scorpion's STX-478. Mechanistically, seems like good news for $RLAY, bad for $OKUR & $COGT↗